Lunch Symposium 4: The new horizon shifts the treatment paradigm in GU carcinoma
2020-08-224. Room 402AB
12:00 ~ 12:25Into the unknown-the importance of HRR (homologous recombination repair) in prostate cancer蘇文彬張延驊, 黃昭淵
12:25 ~ 12:50Optimizing treatment outcomes for your patients with urothelial carcinoma: A look at the present and the future郭哲銓張延驊, 黃昭淵
12:50 ~ 13:00DiscussionAll張延驊, 黃昭淵